Document Detail

Meeting an unmet need in glaucoma: continuous 24-h monitoring of intraocular pressure.
MedLine Citation:
PMID:  22702252     Owner:  NLM     Status:  In-Data-Review    
Intraocular pressure (IOP) is a major risk factor for glaucoma and lowering IOP remains the mainstay of glaucoma treatment. Current glaucoma management usually relies on single IOP measurements during clinic hours despite the fact that the majority of glaucoma patients have their highest IOP levels outside clinic hours. The fact that these IOP peaks go largely undetected may explain why certain patients have progressive disease despite treatment. The search for devices to facilitate continuous 24-h IOP monitoring started over 50 years ago, but only recently have technological advances provided clinicians with a device for continuous IOP monitoring. We discuss the shortcomings of Goldmann Applanation Tonometry, the current gold standard for tonometry, and our experience with the SENSIMED Triggerfish®, a telemetric contact lens sensor for 24-h IOP monitoring. It may be possible to integrate 24-h continuous IOP monitoring into clinical practice, and this has the potential to contribute to the reduction of glaucoma-related vision loss.
Kaweh Mansouri; Robert N Weinreb
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of medical devices     Volume:  9     ISSN:  1745-2422     ISO Abbreviation:  Expert Rev Med Devices     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-06-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101230445     Medline TA:  Expert Rev Med Devices     Country:  England    
Other Details:
Languages:  eng     Pagination:  225-31     Citation Subset:  IM    
Department of Ophthalmology, Hamilton Glaucoma Center, University of California, La Jolla, San Diego, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cardiovascular magnetic resonance for diagnosis of coronary artery disease: quo vadis?
Next Document:  Perspectives on the advanced control of bioreactors for functional vascular tissue engineering in vi...